Description
Investigate the effectiveness of palbociclib (IBRANCE®) when taken in combination with chemotherapy medicines irinotecan (IRN) and temozolomide (TMZ) versus IRN and TMZ alone for the treatment of Ewing sarcoma.
the length of study:21-day treatment cycles
Information
Condition
Recurrent/relapsed Ewing sarcoma
Long-term follow-up
Phone calls or office visit to check in every 2 months for at least 2 years
Sex
Male, Female
Payment
No
Location
Address
Copenhagen
Contact Information
Email
Website